🇺🇸 Insulin Glargine and Insulin Lispro in United States

Insulin Glargine and Insulin Lispro (Insulin Glargine and Insulin Lispro) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Insulin Glargine and Insulin Lispro in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Insulin Glargine and Insulin Lispro approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Insulin Glargine and Insulin Lispro in United States?

GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.